Immunometabolism and Pulmonary Infections: Implications for Protective Immune Responses and Host-Directed Therapies.

ABSTRACT: The biology and clinical efficacy of immune cells from patients with infectious diseases or cancer are associated with metabolic programming. Host immune- and stromal-cell genetic and epigenetic signatures in response to the invading pathogen shape disease pathophysiology and disease outcomes. Directly linked to the immunometabolic axis is the role of the host microbiome, which is also discussed here in the context of productive immune responses to lung infections. We also present host-directed therapies (HDT) as a clinically viable strategy to refocus dysregulated immunometabolism in patients with infectious diseases, which requires validation in early phase clinical trials as adjuncts to conventional antimicrobial therapy. These efforts are expected to be continuously supported by newly

SUBMITTER: Rao M 

PROVIDER: S-EPMC6514247 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature